Cargando…
Low-level light treatment ameliorates immune thrombocytopenia
Immune thrombocytopenia (ITP) is an immune-mediated acquired bleeding disorder characterized by abnormally low platelet counts. We reported here the ability of low-level light treatment (LLLT) to alleviate ITP in mice. The treatment is based on noninvasive whole body illumination 30 min a day for a...
Autores principales: | Yang, Jingke, Zhang, Qi, Li, Peiyu, Dong, Tingting, Wu, Mei X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128784/ https://www.ncbi.nlm.nih.gov/pubmed/27901126 http://dx.doi.org/10.1038/srep38238 |
Ejemplares similares
-
Additive enhancement of wound healing in diabetic mice by low level light and topical CoQ10
por: Mao, Zhigang, et al.
Publicado: (2016) -
CD44 Antibodies and Immune Thrombocytopenia in the Amelioration of Murine Inflammatory Arthritis
por: Mott, Patrick J., et al.
Publicado: (2013) -
Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
por: Cheloff, Abraham Z, et al.
Publicado: (2019) -
Immune Thrombocytopenia: Are We Stuck in the Mud or Is There Light at the End of the Tunnel?
por: Bussel, James, et al.
Publicado: (2019) -
Co-Inhibition of the Immunoproteasome Subunits LMP2 and LMP7 Ameliorates Immune Thrombocytopenia
por: Du, Sheng-hong, et al.
Publicado: (2021)